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Abstract: Recombinant protein production in bacterial cells is commonly performed using 10 
planktonic cultures. However, the natural state for many bacteria is living in communities attached 11 
to surfaces forming biofilms. In this work, a flow cell system was used to compare the production 12 
of a model recombinant protein (enhanced green fluorescent protein, eGFP) between planktonic and 13 
biofilm cells. The fluorometric analysis revealed that when the system was in steady state, the 14 
average specific eGFP production from Escherichia coli biofilm cells was 10-fold higher than in 15 
planktonic cells. Additionally, epifluorescence microscopy was used to determine the percentage of 16 
eGFP-expressing cells in both planktonic and biofilm populations. In steady state, the percentage of 17 
planktonic-expressing cells oscillated around 5%, whereas for biofilms eGFP-expressing cells 18 
represented on average 21% of the total cell population. Therefore, the combination of fluorometric 19 
and microscopy data allowed us to conclude that E. coli biofilm cells can have a higher recombinant 20 
protein production capacity when compared to their planktonic counterparts. 21 
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1. Introduction 24 
Recombinant proteins are currently used in different biotechnological industries and are 25 
produced in large amounts in bioreactors [1]. 26 
An important step in recombinant protein production is to choose the ideal expression system 27 
and factors like protein quality, functionality, production speed and yield should be considered [2]. 28 
Escherichia coli has been widely used for the production of recombinant proteins due to its fast growth 29 
at high cell densities, minimal nutrient requirements, well-characterized genetics and the availability 30 
of a large number of cloning vectors [2, 3]. In the early 1980s, the Food and Drug Administration 31 
(FDA) approved the first recombinant insulin produced in E. coli [4] and since then this bacterium is 32 
one of the organisms of choice for the production of several commercial recombinant proteins [5]. 33 
Most of the research on the expression of recombinant proteins has been based on planktonic 34 
bacteria grown in liquid cultures. However, the natural state for many bacteria is to live in 35 
communities of sessile cells forming biofilms [6]. Biofilms are communities of surface-attached 36 
microorganisms encased in a self-produced extracellular matrix [7]. Such biological organization 37 
provides distinct characteristics to bacteria comparing to their planktonic counterparts [8]. For 38 
instance, local environmental conditions arising as a result of mass transport limitations, intercellular 39 
signaling and other phenomena, may induce biofilm cells to modulate expression of genes differently 40 
than in suspended populations [9]. The expression of recombinant proteins in E. coli is commonly 41 
accomplished by inserting the gene of interest into a multicopy plasmid [10] that imposes a metabolic 42 
burden on the host cell [11]. In planktonic cells, this added metabolic burden may decrease cellular 43 
growth rates and biomass yields [11], particularly when the plasmid vector is used to the direct 44 
Microorganisms 2018, 6, x FOR PEER REVIEW  2 of 7 
 
production of a recombinant protein [12]. In contrast, plasmids were shown to increase biofilm 45 
formation. In 2007, O’Connell et al. [13] examined the production of eGFP in a chemostat with 46 
planktonic cells and in a parallel plate flow cell (PPFC) reactor with biofilm cells. This was the first 47 
experiment showing a high-level production of an heterologous protein in E. coli biofilms. Although 48 
the number of studies on the effect of recombinant protein expression on sessile cells is still scarce, it 49 
has been suggested that the biofilm environment benefits recombinant protein production [14, 15].  50 
The aim of this work was to compare the production of a model recombinant protein (enhanced 51 
green fluorescent protein, eGFP) between E. coli planktonic and biofilm cells. For this purpose, a flow 52 
cell system was used that included a recirculating tank, where planktonic cells grow, and a vertical 53 
flow cell for biofilm formation. Epifluorescence microscopy was used to evaluate the eGFP 54 
production at single-cell level and fluorometry to assess the bulk production.  55 
2. Materials and Methods  56 
Bacterial Strain 57 
The E. coli strain JM109(DE3) from Promega (USA) was transformed with the plasmid pFM23 58 
(constructed from pET28A vector, Novagen, USA) for the cytoplasmic production of eGFP [16].  59 
 60 
Flow Cell System and Experimental Conditions 61 
A reactor system comprising a recirculating tank (planktonic cells), a vertical flow cell reactor 62 
(where biofilms are formed), and peristaltic and centrifuge pumps that allow the circulation of the 63 
bacterial suspension was operated as described by Gomes et al. [17]. The flow cell reactor is a semi-64 
circular Perspex duct with apertures on its flat wall to fit removable Perspex pieces (coupons) to 65 
which polyvinyl chloride (PVC) slides were glued. The biofilms were developed on the upper faces 66 
of the PVC slides that were in contact with the bacterial suspension circulating through the system.  67 
E. coli cells were grown by recirculating the bacterial suspension at 30 °C for 11 days under 68 
turbulent flow (Reynolds number of 4600) [17]. The recirculating tank was aerated using an air pump 69 
(flow rate of 108 l h-1) and continuously fed with lysogeny medium (LB-Miller, Sigma, USA) 70 
supplemented with 20 μg ml–1 kanamycin at a flow rate of 0.025 l h–1 [17]. 71 
 72 
Biofilm and Planktonic Monitoring 73 
The system was stopped daily, and a coupon was carefully removed from the flow cell for 74 
biofilm sampling. The biofilm wet weight and thickness were firstly determined by comparing the 75 
coupon weight prior to the start of the experiment and on the sampling day, and by using a digital 76 
micrometer [18], respectively. Then, the biofilm was resuspended in 25 ml of sterile saline solution 77 
(0.85% NaCl) for total and viable cell quantification and eGFP analysis.  78 
Biofilm total (viable plus non-viable) and viable cell counts were determined using the 79 
Live/Dead® BacLightTM bacterial viability kit (Syto9/propidium iodide; Invitrogen Life Technologies, 80 
Alfagene, Portugal) as fully described in Gomes et al. [17]. Briefly, bacterial cells from the biofilm 81 
suspension were filtered through a Nucleopore Track-Etch Membrane of black polycarbonate (pore 82 
size of 0.22 μm; Whatman Ltd, UK), stained for 10 min in the dark and observed using a Leica DM 83 
LB2 epifluorescence microscope connected to a Leica DFC300 FX camera (Leica Microsystems Ltd, 84 
Switzerland). The image processing software ImageJ v1.48 (NHI, USA) was used to estimate the 85 
number of viable and non-viable cells on each membrane from counts of a minimum of 15 fields of 86 
view. The final values of biofilm total cells were expressed as log cells cm-2 of coupon area and the 87 
percentage of biofilm viability on each day was calculated by dividing the viable cell counts by the 88 
total cell number.  89 
The eGFP expression in biofilm cells was assessed by both epifluorescence microscopy [17] and 90 
fluorometry [16]. For the microscopic method, the biofilm suspension was filtered and observed 91 
using a Leica DM LB2 epifluorescence microscope. Fifteen fields of view were photographed for each 92 
sample in order to estimate the number of eGFP-expressing cells [17]. The percentage of eGFP-93 
expressing cells in the biofilm was then calculated by dividing the number of eGFP-expressing cells 94 
by the total number of cells. The specific eGFP production in biofilms was quantified by the 95 
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fluorometric method fully described by Mergulhão and Monteiro [16]. Briefly, a volume of biofilm 96 
detached cells corresponding to an equivalent optical density (OD) of 1 at 610 nm was centrifuged. 97 
The pellet was resuspended in 100 μl of Buffer I (50 mM Na2HPO4, 300 mM NaCl, pH 8) and added 98 
to 100 μl of Buffer I in a 96-well microtiter plate (Orange Scientific, Belgium). Fluorescence was 99 
measured in a microplate reader (SpectraMax M2E, Molecular Devices, Inc., UK) with a 488 nm-100 
excitation filter and a 507 nm-emission filter. Calibration curves were constructed with purified eGFP 101 
and the final values were presented as specific eGFP production (fg cell−1). An OD610 nm of 1 102 
corresponds to a cellular concentration of 7.6 x 108 cells ml-1. 103 
For monitoring the planktonic cells, a sample was taken from the recirculating tank to first assess 104 
the OD610 nm and the dissolved oxygen (OX 4100 H, Fisher, Germany). Total and viable cell counts, 105 
eGFP-expressing cell counts and specific eGFP production were also assessed as previously described 106 
for the biofilm cells.  107 
 108 
Statistical Analysis  109 
The results presented in Figure 1 originated from averages of triplicate sets obtained in 110 
independent experiments. Standard deviations (SDs) on the triplicate sets were calculated for each 111 
day and parameter. For planktonic growth (Figure 1(a) and 1(b)), the following SD averages were 112 
obtained: SD < 16% for OD610 nm and dissolved oxygen, SD < 4% for total cell counts and SD < 5% for 113 
planktonic viability. Concerning biofilm formation (Figure 1(d) and 1(e)), the following SD averages 114 
were obtained: SD < 23% for biofilm wet weight, SD < 20% for biofilm thickness, SD < 3% for biofilm 115 
total cells and SD < 4% for biofilm viability. Regarding the eGFP quantification (Figure 1(c) and 1(f)) 116 
SD < 19% for planktonic eGFP production, SD < 4% for planktonic eGFP-expressing cells, SD < 8% for 117 
biofilm eGFP production and SD < 4% for biofilm eGFP-expressing cells were obtained. 118 
Paired t-test analysis was performed based on a confidence level of 95% (differences reported as 119 
significant for P values < 0.05). 120 
3. Results 121 
In this work, two fluorescence-based techniques (fluorometry and epifluorescence microscopy) 122 
were used with the aim of comparing the eGFP production in planktonic and biofilm populations 123 
grown in a flow cell system.   124 
Planktonic growth was monitored during 11 days by measuring the OD610 nm and dissolved 125 
oxygen in the recirculating tank (Figure 1(a)) and by quantifying the total cell number and cell 126 
viability (Figure 1(b)). The OD610 nm increased until day 4, which is in agreement with the 127 
corresponding decrease in the oxygen concentration in the recirculating culture over the same 128 
experimental period. Between days 4 and 6, the OD610 nm decreased and then stabilized from day 6 129 
onwards. The same stabilization was observed in the oxygen consumption profile with dissolved 130 
oxygen levels around 2 mg l-1, thus it can be concluded that the flow cell system was in steady state 131 
between days 6 and 11. Looking at Figure 1(b), the total number of planktonic cells remained 132 
practically constant over the experiment. However, the percentage of viability varied significantly 133 
(Figure 1(b)) due to oscillations on the number of viable cells during the experimental time (data not 134 
shown). Between days 4 and 6, a strong decrease in planktonic viability (from 92% to 42%) was 135 
observed. But from day 8 onwards the planktonic viability increased significantly, reaching almost 136 
100% at the end of the experiment.  137 
Regarding the biofilm growth, it was monitored by determining the wet weight and thickness 138 
(Figure 1(d)), and by quantifying the total cell number and cell viability (Figure 1(e)) as performed 139 
for planktonic cells. Biofilm wet weight remained practically constant during the experimental time, 140 
but a slight increase was observed in the last day of the experiment. The evolution of biofilm thickness 141 
was similar to the wet weight with average values around 0.104 mm. Figure 1(e) shows that the total 142 
number of biofilm cells increased slightly between days 2 and 5, remaining constant until the end of 143 
the experiment. Concerning biofilm viability (Figure 1(e)), it is possible to observe a marked reduction 144 
in cell viability until day 5 (38%) that resulted in viability percentages of on average 39% until day 145 
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11. Note that lower viability percentages were found for biofilms (Figure 1(e)) when compared to 146 
planktonic population (Figure 1(b)).  147 
Figure 1. Time-course evaluation of planktonic and biofilm parameters: (a) OD610 nm and dissolved oxygen in the 148 
recirculating tank, (b) planktonic total cells and planktonic viability, (c) planktonic eGFP production and 149 
percentage of planktonic eGFP-expressing cells, (d) biofilm wet weight and thickness, (e) biofilm total cells and 150 
biofilm viability, (f) biofilm eGFP production and percentage of biofilm eGFP-expressing cells. Black circles (●) 151 
and squares (■) on the left y-axis, and grey circles (●) and squares (■) on the right y-axis. The means ± SDs for 152 
three independent experiments are illustrated. 153 
 154 
By analysing the specific eGFP production (Figures 1(c) and (f)), it can be seen that sessile cells 155 
produced more recombinant protein than those grown in planktonic state. The biofilm environment 156 
enhanced the specific eGFP expression about 10-fold when compared to planktonic cells in steady 157 
state (statistically significant differences were confirmed for all experimental days, P < 0.05, except on 158 
day 2). Additionally, epifluorescence microscopy was used to determine the percentage of eGFP-159 
expressing cells in both planktonic (Figure 1(c)) and biofilm populations (Figure 1(f)). The percentage 160 
of eGFP-expressing cells in planktonic state started to increase at day 3, reaching a maximum value 161 
of 76% at day 4 and then decreasing abruptly to values around 5% (Figure 1(c)). The equivalent 162 
biofilm curve (Figure 1(f)) also shows an initial increase in the percentage of expressing cells (with a 163 
maximum value of 87% between days 3 and 4), followed by a strong reduction (of approximately 164 
58%) until day 6. In steady state, the percentage of planktonic expressing cells oscillated around 5%, 165 
whereas for biofilms, eGFP-expressing cells represented on average 21% of total cell population. 166 
Combining this information with the fluorimetric data, it is possible to conclude that E. coli biofilm 167 
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cells can have a higher recombinant production capacity when compared to their planktonic 168 
counterparts. 169 
 170 
4. Discussion 171 
In this study, the production of a model recombinant protein (eGFP) in E. coli planktonic and 172 
biofilm cells was evaluated by fluorometry (a bulk method) and epifluorescence microscopy (a single-173 
cell method).  174 
We found that the specific eGFP production was lower in planktonic cells and this may have 175 
contributed to the higher viability of these cells when compared to biofilm cells. It is well documented 176 
that cells bearing a plasmid may suffer from a metabolic burden as cellular resources are being used 177 
for its replication and for the expression of plasmid-encoded genes [11, 19, 20]. In particular, a 178 
decreased cellular viability of plasmid-bearing cells and an increased protease activity are some stress 179 
signals suffered by these cells [21, 22].  180 
The expression of recombinant proteins in E. coli biofilms was first reported by Huang et al. [23-181 
25], who have studied the production of β-galactosidase in a chemostat and in a parallel plate flow. 182 
These authors found that the recombinant protein was successfully produced in biofilm cells, 183 
although at low level than in planktonic cells [23, 25]. In contrast, our results show that the E. coli 184 
biofilm environment enhanced eGFP production when compared to planktonic cells. This result 185 
corroborates that obtained in a previous study of O’Connell et al. [13] who produced eGFP in a 186 
chemostat (planktonic cells) and in a PPFC reactor (biofilms). The results of their work indicated that 187 
the biofilm environment enhanced both plasmid maintenance and cellular GFP concentrations when 188 
compared to planktonic cells. Continuous biofilm cultures for recombinant protein production can 189 
be more beneficial for retention of plasmid-bearing cells than chemostats [13] since cells in biofilms 190 
tend to grow more slowly than their planktonic counterparts [26], leading to fewer divisions and 191 
correspondingly less plasmid segregation. More recently, our research group found that the 192 
volumetric productivity of the biofilms developed in the flow cell system is already within the range 193 
that can be obtained by conventional high cell density cultures, even before optimization of 194 
cultivation conditions [14].  195 
During recombinant protein production, it is essential to monitor the amount of target protein 196 
produced in order to find the best processing conditions. The use of a fluorescent protein as a model 197 
recombinant protein enables bulk and single-cell quantification. Bulk production can be assessed by 198 
fluorometry, which is a high sensitive, specific and simple method with low instrumental costs when 199 
compared to other techniques, like flow cytometry, that are also used to follow recombinant protein 200 
expression [27, 28]. On the other hand, single-cell analysis by epifluorescence microscopy can provide 201 
information about the heterogeneity level of protein expression within a cell population [29]. In this 202 
work, the combination of these two techniques showed to be very useful in monitoring recombinant 203 
protein production in both planktonic and sessile cells. 204 
5. Conclusions 205 
This study revealed that the specific recombinant protein production and the percentage of 206 
eGFP-expressing cells were higher in E. coli biofilms than in cell suspension. When combined with a 207 
bulk method such as fluorimetry, epifluorescence microscopy and the corresponding image analysis 208 
is a valuable tool for determining important production parameters in both planktonic and sessile 209 
cells, including the number of cells expressing the recombinant protein within a bacterial population. 210 
The information extracted with such single-cell technique can be further used to find the best 211 
processing conditions for recombinant protein production in both types of cells. 212 
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